alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › cerebrovascular-amyloid

cerebrovascular-amyloid

3 studies tagged cerebrovascular-amyloid, dated 1989-11-01 to 2013-12-09. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain 2013-12-09
  2. Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy 2008-08-20
  3. Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance 1989-11-01

Studies

3 studies carry this tag.

Date range

1989 to 2013

Top journals

  • Biomaterials 1
  • Laboratory investigation; a journal of technical methods and pathology 1
  • Pharmaceutical research 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Biomaterials 2013-12-09 Treatments

    Cerebral amyloid angiopathy (CAA) results from the accumulation of Aβ proteins primarily within the media and adventitia of small arteries and capillaries of the cortex and leptomeninges.

  2. Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Pharmaceutical research 2008-08-20 Treatments

    SNVs are capable of carrying a payload of model protein across the BBB to target cerebral amyloid.

  3. Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Laboratory investigation; a journal of technical methods and pathology 1989-11-01 Drug development

    In Alzheimer's disease, three types of pathologic lesions are stained by thioflavin: neurofibrillary tangles, senile plaques, and amyloidaceous vessels.

All topic tags with their study counts